menu
    • menu

    Company profile for Enterome

    NEW Drugs in Dev.: 7
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system. Enterome’s Mimicry drug discovery platform uses best-in-class biocomputational tools & bioassays to ide...
    Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system. Enterome’s Mimicry drug discovery platform uses best-in-class biocomputational tools & bioassays to identify novel therapeutics from its proprietary database of 20+ million full-length gut microbiome proteins. This platform is highly productive & has already generated multiple pipelines of transformative drug candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnteromeFrance Flag
    Country
    Country
    France
    Address
    Address
    94/96 avenue Ledru-Rollin 75011 Paris
    Telephone
    Telephone
    +33 (0)1 75 77 27 85
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enterome.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enterome/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/enteromesa

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enterome Unveils Enhanced Interim Phase 2 Data For Oncomimics
    Enterome Unveils Enhanced Interim Phase 2 Data For Oncomimics

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202073/0/en/Enterome-presents-strengthened-interim-Phase-2-results-for-lead-OncoMimics-immunotherapy-EO2463-to-treat-follicular-lymphoma-at-ASH.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Enterome's EO2401 Demonstrates Survival Benefit in Phase 2 GBM
    Enterome's EO2401 Demonstrates Survival Benefit in Phase 2 GBM

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197607/0/en/Enterome-OncoMimics-immunotherapy-EO2401-shows-survival-benefit-in-Phase-2-glioblastoma-trial.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Enterome's Oncomimics™ EO2463 Granted FDA Fast Track Designation
    Enterome's Oncomimics™ EO2463 Granted FDA Fast Track Designation

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167636/0/en/Enterome-receives-FDA-Fast-Track-designation-in-follicular-lymphoma-for-lead-OncoMimics-immunotherapy-EO2463.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Enterome Shares Positive Ph2 Results for EO2463 in iNHL
    Enterome Shares Positive Ph2 Results for EO2463 in iNHL

    23 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/23/3103112/0/en/Enterome-presents-positive-Phase-2-interim-results-in-relapsed-refractory-indolent-non-Hodgkin-lymphoma-after-EO2463-OncoMimics-immunotherapy-treatment-at-ICML.html

    GLOBENEWSWIRE
    23 Jun 2025
    Share Share
    Enterome raises $19M for OncoMimics™ to treat Follicular Lymphoma
    Enterome raises $19M for OncoMimics™ to treat Follicular Lymphoma

    12 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/12/3098067/0/en/Enterome-raises-19-million-to-fund-clinical-development-of-its-OncoMimics-immunotherapy-to-treat-Follicular-Lymphoma.html

    GLOBENEWSWIRE
    12 Jun 2025
    Share Share
    Enterome to present Phase 2 data for OncoMimics EO2463 at ICML
    Enterome to present Phase 2 data for OncoMimics EO2463 at ICML

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091776/0/en/Enterome-to-present-positive-Phase-2-indolent-non-Hodgkin-lymphoma-data-for-its-OncoMimics-EO2463-at-ICML.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search